Key statistics
As of last trade Shield Therapeutics PLC (1JS:FRA) traded at 0.111, -24.49% below its 52-week high of 0.147, set on Jan 16, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.111 |
|---|---|
| High | 0.111 |
| Low | 0.111 |
| Bid | 0.111 |
| Offer | 0.131 |
| Previous close | 0.114 |
| Average volume | 11.19k |
|---|---|
| Shares outstanding | 1.07bn |
| Free float | 304.54m |
| P/E (TTM) | -- |
| Market cap | 112.26m GBP |
| EPS (TTM) | -0.0177 GBP |
Data delayed at least 15 minutes, as of Feb 12 2026 07:04 GMT.
More ▼
Announcements
- FDA Grants additional Exclusivity for ACCRUFeR
- Total Voting Rights
- Approval for ACCRUFeR in China expected in Q1 2026
- Q4 2025 Trading Update
- Block listing 6 Monthly Return
- Total Voting Rights
- FDA approves extension for ACCRUFeR®
- Block Listing Application
- Shield Wins Gold at Titan Branding Awards
- Amends Senior Secured Debt Financing
More ▼
